









Mercado
/
Acciones
/
nasdaq-enov
/

Enovis Corp

ENOV

26.290USD

-4.570-14.81%

Cierre 07/18, 16:00（ET）Cotizaciones retrasadas 15 min

1.50BCap. mercado

PérdidaP/E TTM



Enovis Corp

26.290

-4.570-14.81%

Descripción general Compañía Finanzas

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

Información de la empresa

Símbolo de cotizaciónENOV

Nombre de la empresaEnovis Corp

Fecha de salida a bolsaMay 08, 2008

Fundada en1998

Director ejecutivoMr. Damien Mcdonald

Número de empleados7367

Tipo de seguridadOrdinary Share

Fin del año fiscalMay 08

Dirección2711 Centerville Road

CiudadWILMINGTON

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal19808

Teléfono13022529160

Sitio Webhttps://www.enovis.com/

Símbolo de cotizaciónENOV

Fecha de salida a bolsaMay 08, 2008

Fundada en1998

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Daniel Alexis Pryor

Executive Vice President - Strategy and Business Development

104.51K

+18.11%

Mr. Damien Mcdonald

Chief Executive Officer, Director

96.30K

Mr. Terry D. Ross

Group President - Prevention and Recovery

36.11K

+90.73%

Ms. Sharon L. Wienbar

Independent Chairman of the Board

28.26K

+30.46%

Mr. Rajiv Vinnakota

Independent Director

20.37K

+47.89%

Mr. Liam J. Kelly

Independent Director

15.27K

+76.12%

Ms. Barbara W. Bodem

Independent Director

10.52K

+168.36%

Dr. Christine Ortiz, Ph.D.

Independent Director

10.52K

+168.36%

Mr. Philip A. Okala

Independent Director

Ms. Angela S. Lalor

Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Daniel Alexis Pryor

Executive Vice President - Strategy and Business Development

104.51K

+18.11%

Mr. Damien Mcdonald

Chief Executive Officer, Director

96.30K

Mr. Terry D. Ross

Group President - Prevention and Recovery

36.11K

+90.73%

Ms. Sharon L. Wienbar

Independent Chairman of the Board

28.26K

+30.46%

Mr. Rajiv Vinnakota

Independent Director

20.37K

+47.89%

Mr. Liam J. Kelly

Independent Director

15.27K

+76.12%

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

International Reconstructive

148.37M

26.55%

U.S. Reconstructive

137.88M

24.67%

U.S. Bracing & Support

115.09M

20.59%

International P&R

90.88M

16.26%

U.S. Other P&R

66.62M

11.92%

Sin datos

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

International Reconstructive

148.37M

26.55%

U.S. Reconstructive

137.88M

24.67%

U.S. Bracing & Support

115.09M

20.59%

International P&R

90.88M

16.26%

U.S. Other P&R

66.62M

11.92%

Estadísticas de accionistas

Actualizado: jue., 10 de jul

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

11.41%

The Vanguard Group, Inc.

10.64%

American Century Investment Management, Inc.

6.17%

Davenport Asset Management

5.38%

Dimensional Fund Advisors, L.P.

5.12%

Other

61.27%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

11.41%

The Vanguard Group, Inc.

10.64%

American Century Investment Management, Inc.

6.17%

Davenport Asset Management

5.38%

Dimensional Fund Advisors, L.P.

5.12%

Other

61.27%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor/Hedge Fund

46.99%

Investment Advisor

45.59%

Hedge Fund

7.67%

Research Firm

4.24%

Individual Investor

1.55%

Bank and Trust

1.35%

Pension Fund

1.15%

Family Office

0.05%

Sovereign Wealth Fund

0.05%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

630

68.25M

119.48%

-3.27M

2025Q1

646

68.39M

119.73%

-3.70M

2024Q4

637

64.20M

113.02%

-5.55M

2024Q3

613

62.53M

111.92%

-6.94M

2024Q2

617

64.91M

118.38%

-5.04M

2024Q1

651

62.70M

114.40%

-9.13M

2023Q4

661

61.64M

112.95%

-6.99M

2023Q3

653

60.52M

110.96%

-10.76M

2023Q2

641

59.95M

109.96%

-8.07M

2023Q1

643

57.38M

105.33%

-9.99M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

6.52M

11.41%

+1.67M

+34.39%

Mar 31, 2025

The Vanguard Group, Inc.

6.08M

10.64%

-7.15K

-0.12%

Mar 31, 2025

American Century Investment Management, Inc.

3.52M

6.17%

+369.48K

+11.71%

Mar 31, 2025

Davenport Asset Management

3.07M

5.38%

-206.82K

-6.31%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

2.93M

5.12%

+27.89K

+0.96%

Mar 31, 2025

Royce Investment Partners

2.49M

4.36%

+20.23K

+0.82%

Mar 31, 2025

State Street Global Advisors (US)

1.89M

3.32%

+162.41K

+9.37%

Mar 31, 2025

Diamond Hill Capital Management Inc.

1.87M

3.28%

-918.91K

-32.92%

Mar 31, 2025

Hood River Capital Management LLC

1.44M

2.53%

+781.15K

+118.10%

Mar 31, 2025

River Road Asset Management, LLC

1.39M

2.44%

+153.53K

+12.40%

Mar 31, 2025

ETFs relacionados

Actualizado: dom., 6 de jul

Nombre

Proporción

SPDR S&P Health Care Equipment ETF

1.7%

Invesco S&P SmallCap Health Care ETF

1.27%

Invesco S&P SmallCap 600 Pure Value ETF

0.53%

VictoryShares US Small Mid Cap Value Momentum ETF

0.3%

iShares S&P Small-Cap 600 Value ETF

0.29%

SPDR S&P 600 Small Cap Value ETF

0.28%

First Trust Small Cap Growth AlphaDEX Fund

0.28%

iShares U.S. Medical Devices ETF

0.2%

Avantis US Small Cap Equity ETF

0.2%

DFA Dimensional US Small Cap Value ETF

0.18%

SPDR S&P Health Care Equipment ETF

Proporción1.7%

Invesco S&P SmallCap Health Care ETF

Proporción1.27%

Invesco S&P SmallCap 600 Pure Value ETF

Proporción0.53%

VictoryShares US Small Mid Cap Value Momentum ETF

Proporción0.3%

iShares S&P Small-Cap 600 Value ETF

Proporción0.29%

SPDR S&P 600 Small Cap Value ETF

Proporción0.28%

First Trust Small Cap Growth AlphaDEX Fund

Proporción0.28%

iShares U.S. Medical Devices ETF

Proporción0.2%

Avantis US Small Cap Equity ETF

Proporción0.2%

DFA Dimensional US Small Cap Value ETF

Proporción0.18%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Mar 18, 2022

Merger

3<1

Mar 18, 2022

Merger

3<1

Mar 18, 2022

Merger

3<1

Mar 18, 2022

Merger

3<1

Fecha

Tipo

Relación

Mar 18, 2022

Merger

3<1

Mar 18, 2022

Merger

3<1

Mar 18, 2022

Merger

3<1

Mar 18, 2022

Merger

3<1

KeyAI

